Jian Pi Li Qi Decoction Alleviated Postembolization Syndrome Following Transcatheter Arterial Chemoembolization for Hepatocellular Carcinoma

@inproceedings{Xu2016JianPL,
  title={Jian Pi Li Qi Decoction Alleviated Postembolization Syndrome Following Transcatheter Arterial Chemoembolization for Hepatocellular Carcinoma},
  author={Litao Xu and Shiying Wang and Liping Zhuang and Junhua Lin and Hao Chen and Xiaoyan Zhu and Wenying Bei and Qi Zhao and Hongbin Wu and Zhiqiang Meng},
  booktitle={Integrative cancer therapies},
  year={2016}
}
OBJECTIVE To evaluate the effectiveness of Jian Pi Li Qi (JPLQ) decoction in improving quality of life of patients with hepatocellular carcinoma (HCC) following transcatheter arterial chemoembolization (TACE). METHODS A randomized, double-blind, placebo-controlled trial was conducted. A total of 150 patients with HCC were randomly assigned into 3 groups. Groups were designed as follows: neither herbal medicine nor placebo administration (group A), placebo treatment (group B), and JPLQ… CONTINUE READING
Recent Discussions
This paper has been referenced on Twitter 1 time over the past 90 days. VIEW TWEETS

References

Publications referenced by this paper.
Showing 1-10 of 13 references

Qingre Jiedu Decoction” combined western medicine in preventing and treating syndromes after transcatheter arterial chemoembolization in middle-late primary liver cancer

  • Z Qian, G Xie, X Guo
  • Shanghai J Tradit Chin Med
  • 2012

Prognosis risk factors and therapeutic effect analysis in primary hepatic carcinoma: 394 cases report

  • ZQ Meng, LM Liu, X Ma
  • China Oncol
  • 2007

The alleviation of TACE syndrome in liver cancer by Chinese herbs: a clinical research

  • X Chen, P Zhang, P Hu, G Huang, B. Xu
  • China Oncol
  • 2001

Similar Papers

Loading similar papers…